๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight
NCT07017179Obesity/Overweight
AstraZeneca
Phase 2
14
Jinan, Nanjing, Shanghai
2025-05-20
Recruiting
A Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer
NCT07080021Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma
Ruijin Hospital
Observational
119
Shanghai
2025-05-20
Active, closed
JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC
NCT06944470NSCLC
Shanghai Junshi Bioscience Co., Ltd.
Phase 2
78
Guangzhou
2025-05-20
Recruiting
A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT07050459Locally Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
220
Beijing, Haerbin, Zhengzhou, Changsha, Nanjing, Jinan, Shanghai, Chengdu
2025-05-20
Recruiting
A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy Subjects
NCT07001436Renal Insufficiency
Henan Genuine Biotech Co., Ltd.
Phase 1
40
Beijing
2025-05-20
Recruiting
Exergame-assisted Simultaneous Motor-cognitive Training for Middle-aged Old Adults in China
NCT07085663Subjective Cognitive Decline
The Hong Kong Polytechnic University
Not applicable
30
Chengdu
2025-05-20
Not yet open
AI-based Prediction Model of Difficult Tracheal Intubation Using Medical Image Parameters
NCT06982144Difficult Airway
Mu Dong Liang
Observational
228
Beijing
2025-05-20
Not yet open
Effect of Opioid-free Anaesthesia on Postoperative Delirium in Elderly Patients Undergoing Gastrointestinal Surgery
NCT06958393Delirium - Postoperative, Opioid-Free Anaesthesia
Qianfoshan Hospital
Phase 4
406
Jinan
2025-05-20
Not yet open
Analysis of Factors Associated With The Occurrence of Amniotic Fluid Entry in Patients Undergoing Caesarean Section
NCT06991985Amniotic Fluid Embolism
Second Hospital of Shanxi Medical University
Observational
120
Taiyuan
2025-05-20
Recruiting
Use of Nasal Pressure to Assess Inspiratory Effort Under Different Oxygen Treatments
NCT06970990Critical Care, Inspiratory Effort
Jian-Xin Zhou
Not applicable
26
Beijing
2025-05-20
Not yet open
Treatment of Transfusion-dependent Nonsevere Aplastic Anemia With Luspatercept: a Multicenter Prospective Clinical Study
NCT06964971Transfusion-dependent Non-severe Aplastic Anemia
The First Affiliated Hospital of Zhejiang Chinese Medical University
Not applicable
90
Hangzhou
2025-05-20
Recruiting
Efficacy and Safety Assessment of Temporal Interference Stimulation to Improve Bipolar Depression
NCT07021508Bipolar Depression
First Affiliated Hospital of Zhejiang University
Not applicable
160
Hangzhou
2025-05-20
Not yet open
Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia
NCT06971913SLE (Systemic Lupus), CMV
Peking University People's Hospital
Phase 2
100
Beijing
2025-05-20
Recruiting
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370Heart Failure
Boehringer Ingelheim
Phase 3
4,200
Beijing, Changchun, Changde, Changsha, Chengdu, Chenzhou, Chongqing, Dalian
2025-05-20
Recruiting
Establishment of Diagnosis and Classification System for Lung Interstitial and Airway Diseases (LIAD)
NCT06987266Interstitial Lung Diseases (ILD), Airway Disease
Xiangya Hospital of Central South University
Observational
900
Changsha
2025-05-20
Recruiting
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
NCT06977581Asthma
Pfizer
Phase 2
252
Beijing, Guangzhou, Baotou, Hohhot, Najing, Nanjing, Xuzhou, Nanchang
2025-05-20
Recruiting
An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis
NCT06613490Antisynthetase Syndrome, Rheumatoid Arthritis
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1
24
Nanjing
2025-05-20
Not yet open
A Study of Cetuximabฮฒ Combined With Envolimab and mFOLFOX6 in Subjects With Advanced Colorectal Cancer
NCT07000305Advanced Colorectal Cancer
Tao Zhang
Phase 2
42
Wuhan
2025-05-20
Recruiting
Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma
NCT06980259Soft Tissue Sarcoma (STS)
Shandong Cancer Hospital and Institute
Not applicable
106
Jinan
2025-05-20
Recruiting
Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort Study
NCT07037576Breast Cancer Patients
Henan Cancer Hospital
Observational
104
Henan
2025-05-20
Recruiting
Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors
NCT06938880Advanced Solid Tumor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2
60
Guangzhou
2025-05-20
Recruiting
Perioperative Treatment of Hepatoid Adenocarcinoma of Stomach
NCT06992362Hepatoid Adenocarcinoma of Stomach
Peking University Cancer Hospital & Institute
Phase 2
30
Beijing
2025-05-20
Recruiting
IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome
NCT06451198Coronary Artery Disease, Antiplatelet Drugs
Shanghai Zhongshan Hospital
Phase 4
2,846
Shanghai
2025-05-19
Recruiting
Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD๏ผˆ Breakthrough Invasive Fungal Disease๏ผ‰ in Patients With Malignant Hematological Diseases
NCT07135778Invasive Fungal Disease
Institute of Hematology & Blood Diseases Hospital, China
Observational
36
Tianjin
2025-05-19
Active, closed
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
NCT06972472Obesity, Overweight, Type 2 Diabetes
Eli Lilly and Company
Phase 3
600
Beijing, Chengdu, Chongqing, Guangzhou, Harbin, Hefei, Jinan, Luoyang Shi
2025-05-19
Recruiting
Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis
NCT07562542Systemic Mastocytosis, KIT-D816V Mutation
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2025-05-19
Recruiting
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
NCT06702553Nitric Oxide, Cardiac Surgery, Cardiopulmonary Bypass, Adult Patients Undergoing Cardiovascular Surgery With Cardiopulmonary Bypass
Xijing Hospital
Phase 3
3,650
Xi'an
2025-05-19
Recruiting
To Evaluate the Effect of Food on the Pharmacokinetics of Y-4 Tablets in Healthy Subjects
NCT07013773Healthy Male and Female Subjects
Beijing Tiantan Hospital
Phase 1
20
Beijing
2025-05-19
Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
NCT06830798Delayed Graft Function, DGF, Kidney Transplant
Alexion Pharmaceuticals, Inc.
Phase 3
450
Guangzhou, Hangzhou, Hengyang, Nanning, Shenzhen, Taiyuan, Tianjin, Zhengzhou
2025-05-19
Recruiting
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
NCT06711887Lupus Nephritis
Novartis Pharmaceuticals
Phase 3
348
Guangzhou, Shantou, Shenzhen, Liuzhou, Wuhan, Changchun, Shenyang, Binzhou
2025-05-19
Recruiting
Clinical Study on the Diagnosis of Colorectal Lesions by Real-time Artificial Intelligence Assisted Endocytoscopy Combined With Narrow Band Imaging
NCT06982885Endocytoscopy
The First Hospital of Jilin University
Observational
500
Changchun
2025-05-19
Recruiting
Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus
NCT06881290Lupus Erythematosus, Systemic
Chinese SLE Treatment And Research Group
Phase 1
20
Beijing
2025-05-19
Recruiting
A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
NCT06978647Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), Inflammatory Myopathy, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
China Immunotech (Beijing) Biotechnology Co., Ltd.
Phase 1
12
Beijing
2025-05-19
Not yet open
Acupuncture for Anxiety and Depression
NCT06994351Anxiety and Depression, Breast Cancer Survivor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not applicable
20
Beijing
2025-05-18
Not yet open
A Prospective Study on IVUS and DSA Guidance in the Treatment of Budd-Chiari Syndrome
NCT06960473Budd-Chiari Syndrome
The Affiliated Hospital of Xuzhou Medical University
Not applicable
260
Xuzhou
2025-05-18
Recruiting
PBC Long-term Outcomes Study
NCT07149675Primary Biliary Cholangitis (PBC), Long-term Outcomes, Prognosis, Multicenter Prospective Study
Beijing Friendship Hospital
Observational
4,000
Beijing
2025-05-18
Recruiting
Effect of Semi-elemental Enteral Nutrition on Gastrointestinal Tolerance in Patients With Traumatic Brain Injury.
NCT07092423Traumatic Brain Injury, Neurocritical Care, Enteral Feeding Intolerance
Tang-Du Hospital
Not applicable
100
Xi'an
2025-05-18
Not yet open
Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
NCT06970951Systemic Lupus Erythematosus, Rheumatoid Arthritis, Dry Syndrome, Idiopathic Inflammatory Myopathies
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1
15
Suzhou
2025-05-18
Recruiting
A Phase I Clinical Study of a Single Dose of KLA480
NCT07030790Healthy Participants
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Phase 1
20
Shanghai
2025-05-17
Recruiting
Bidirectional Cohort Study of Nanfang Spondyloarthritis
NCT06988813Spondyloarthritis (SpA), Ankylosing Spondylitis (AS)
Nanfang Hospital, Southern Medical University
Observational
3,000
Guangzhou
2025-05-17
Recruiting
Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy
NCT06985485Acute Lymphoblastic Leukemia, Immunotherapy, Blinatumomab, Inotuzumab Ozogamicin
The First Affiliated Hospital of Soochow University
Phase 2
26
Suzhou
2025-05-17
Active, closed
Myopia Progression With Freeform Myopia Control Spectacles
NCT06927388Myopia, Progressive
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
180
Shanghai
2025-05-17
Not yet open
A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of XH-S004 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis
NCT06981091Non-Cystic Fibrosis Bronchiectasis
S-INFINITY Pharmaceuticals Co., Ltd
Phase 2
231
Shanghai
2025-05-16
Recruiting
Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118
NCT07033234Psoriasis
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
142
Hangzhou
2025-05-16
Recruiting
A Study of SH009 Injection in Patients With Advanced Solid Tumors.
NCT07390838Liver Cancer (Locally Advanced or Metastatic), Lung Cancer (NSCLC), Head and Neck Cancer Squamous Cell Carcinoma, Breast Cancer (Locally Advanced or Metastatic)
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Phase 1
150
Shanghai
2025-05-16
Recruiting
A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma
NCT07063888Intrahepatic Cholangiocarcinoma (Icc), Adjuvant Chemoradiotherapy, Narrow Margin, Lymph Node Involvement
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
66
Beijing
2025-05-16
Recruiting
The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients
NCT07147335Cirrhosis, Hepotacellular Carcinoma
The First Affiliated Hospital of University of South China
Observational
800
Hengyang
2025-05-16
Recruiting
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
NCT06947993Atopic Dermatitis
Novartis Pharmaceuticals
Phase 2
224
Guangzhou, Shantou, Changsha, Changchun, Hangzhou, Beijing, Shanghai
2025-05-16
Recruiting
Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
NCT06880276Atopic Dermatitis
Qilu Pharmaceutical Co., Ltd.
Phase 3
360
Shenyang
2025-05-16
Recruiting
TN Induction and Adjuvant Therapy for Resectable Local Recurrent Nasopharyngeal Carcinoma
NCT06912711Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2
70
Guangzhou
2025-05-16
Recruiting
Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma
NCT06883526Lymphoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2
60
Hangzhou
2025-05-16
Recruiting
Adebrelimab With Chemoradiotherapy and Surgery for G/GEJ
NCT06985602Gastroesophageal Adenocarcinoma, Gastric Adenocarcinoma
Jiangsu Cancer Institute & Hospital
Phase 2
30
Nanjing
2025-05-16
Recruiting
HS-10542 Study in Healthy Participants
NCT07040046Healthy
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
100
Qingdao
2025-05-16
By invitation
Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation.
NCT07162688Graft-Versus-Host Disease(GVHD)
Fujian Medical University
Phase 1/2
30
Fuzhou
2025-05-16
Active, closed
Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)
NCT06898957Small Cell Lung Cancer
Amgen
Phase 1
29
Jinan, Chengdu, Fuzhou
2025-05-16
Recruiting
Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer๏ผˆNeo-Color๏ผ‰
NCT06949111Colon Cancer
Hebei Medical University Fourth Hospital
Phase 2
128
Shijiazhuang
2025-05-15
Recruiting
Goal Commitment and Proactive Health Behavior in Chronic Disease Patients
NCT07552571Hypertension, Diabetes Mellitus, Dyslipidemia
Xiong Juyang
Not applicable
600
Wuhan
2025-05-15
Not yet open
AI-driven Automated Biomedical Research
NCT06962423Biomedical Research, Artificial Intelligence (AI)
Tsinghua University
Not applicable
40
Beijing
2025-05-15
Recruiting
Research on the Application of Nursing Intervention Based on ITHBC Theory in Postoperative Self-Management of Patients With Varicose Veins of the Lower Extremities
NCT07570277Varicose Veins
Second Affiliated Hospital of Nanchang University
Not applicable
104
Nanchang
2025-05-15
Recruiting
A Study on the Efficacy and Safety of Golidocitinib Combined With Tislelizumab and Chemotherapy as First-line Treatment for Advanced NSCLC
NCT06969612NSCLC (Advanced Non-small Cell Lung Cancer)
Peking University Cancer Hospital & Institute
Phase 1
21
Beijing
2025-05-15
Recruiting
A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia
NCT07028073Acute Myeloid Leukemia With T(8;21)(Q22;Q22), Acute Myeloid Leukemia With T(16;16)(P13;Q22), KIT Gene Mutation, Avapritinib
The First Affiliated Hospital of Soochow University
Phase 1/2
78
Suzhou
2025-05-15
Not yet open
Evaluation of AI-Generated Clinical Advice by Physicians
NCT06980467Artificial Intelligence (AI)
Tsinghua University
Not applicable
8
Beijing, Wuxi
2025-05-15
Active, closed
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
NCT06993792Obesity, Overweight, Type 2 Diabetes
Eli Lilly and Company
Phase 3
1,400
Beijing, Chengdu, Chongqing, Guangzhou, Harbin, Hefei, Jinan, Luoyang Shi
2025-05-15
Active, closed
Neoadjuvant Therapy ๏ผˆNALIRIFOX๏ผ‰ for Locally Advanced Colon and Upper Rectal Cancer
NCT07020468Colorectal Cancer (CRC)
Affiliated Cancer Hospital of Shantou University Medical College
Phase 4
57
Shantou
2025-05-15
Recruiting
Clinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU
NCT07391618Advanced Colorectal Cancer
Chinese PLA General Hospital
Phase 2
583
Beijing
2025-05-15
Not yet open
Endoscopic Cryoablation Combined With PD-1 in Advanced Gastric Cancer
NCT06759233Gastric Cancer
Zhongguang Luo, MD
Phase 2
15
Shanghai
2025-05-15
Not yet open
SONICURE๏ผˆSONICracker for the Treatment of UndeRExpansion๏ผ‰
NCT06924736Coronary Artery Disease
Shanghai Bluesail Boyuan Medical Technology Co., Ltd.
Not applicable
200
Beijing
2025-05-15
Recruiting
A Vision-Language Foundation Model for Brain Disease Diagnosis From Multimodal Data
NCT07126821Brain (Nervous System) Cancers, Brain Arterial Disease, Neuro-Degenerative Disease, Brain Tumors
Xiangya Hospital of Central South University
Observational
100,000
Changsha
2025-05-15
Recruiting
Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
NCT06949033Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]), Neoadjuvant Therapy, Adjuvant Chemotherapy, pCR Rate
Zuoyi Jiao
Phase 3
668
Lanzhou
2025-05-15
Recruiting
A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-low Recurrent/Metastatic Breast Cancer
NCT06957886HER2-low Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
566
Guangzhou, Changsha
2025-05-15
Recruiting
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
NCT06990867Acute Ischemic Stroke
Corxel Pharmaceuticals
Phase 2/3
740
Baotou, Beijing, Changchun, Guangzhou, Harbin, Kaili, Linfen, Nanyang
2025-05-15
Recruiting
A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Interstitial Lung Disease
NCT06992661Interstitial Lung Disease (ILD), Healthy Volunteers
Ruijin Hospital
Phase 1
84
Shanghai
2025-05-15
Active, closed
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
NCT06972459Obesity, Overweight
Eli Lilly and Company
Phase 3
800
Beijing, Chengdu, Chongqing, Guangzhou, Harbin, Hefei, Jinan, Luoyang Shi
2025-05-15
Recruiting
Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate Cancer
NCT07056790Prostate CA
First Affiliated Hospital of Fujian Medical University
Phase 1/2
40
Fuzhou
2025-05-15
Not yet open
Magnesium-L-Threonate Improves Menopausal Symptoms
NCT06959745Menopause Syndrome, Magnesium
Guangdong Provincial People's Hospital
Not applicable
50
Guangzhou
2025-05-15
Not yet open
Stereotactic Intracerebral Injection of IPSC-DAPs in Patients with Parkinson's Disease
NCT06821529Parkinson Disease
iCamuno Biotherapeutics Ltd.
Phase 1
12
Hangzhou
2025-05-15
Recruiting
Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.
NCT07489989Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Daihong Liu
Phase 2
30
Beijing
2025-05-15
Not yet open
A Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
NCT06944496Gastric Carcinoma
RemeGen Co., Ltd.
Phase 3
616
Beijing
2025-05-15
Not yet open
Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma
NCT06927128UTUC, NAC
Changhai Hospital
Phase 2
45
Shanghai
2025-05-15
Recruiting
A Study on the Effect of Electronic Moxibustion Based on Ziwu Liuzhu in Treating Constipation in Stroke Patients
NCT07372326Stroke Patients With Constipation
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Not applicable
105
Jinhua
2025-05-15
Active, closed
Amphotericin B Versus Isavuconazole for Mucormycosis: A Comparative Efficacy and Safety Study
NCT07191756Mucormycosis
Qiu Ye
Observational
150
Nanning
2025-05-15
Not yet open
Study of Concomitant Administration of the sIPV and DTaP or MMR
NCT06920069Polio, Diphteria, Tetanus and Pertussis, MMR Vaccine
Institute of Medical Biology, Chinese Academy of Medical Sciences
Phase 4
2,640
Chuxiong, Puer, Wenshan, Yisa
2025-05-15
Recruiting
A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors
NCT06954077Gastrointestinal Tumor, Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
45
Guangzhou
2025-05-15
Not yet open
Multimodal Imaging and Biospecimen Collection for Low Back Pain (LBPB)
NCT06967363Chronic Low Back Pain (CLBP), Acute Low Back Pain, Low Back Pain, Chronic Pain
Peking University Third Hospital
Observational
360
Beijing
2025-05-15
Recruiting
Drug- Eluting Stent for Symptomatic Intracranial Arterial Stenosis
NCT07197970Symptomatic Intracranial Atherosclerotic Stenosis
Beijing Tiantan Hospital
Phase 3
224
Beijing
2025-05-15
Recruiting
Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Carriers
NCT06966232Gastrointestinal Cancers
Sun Yat-sen University
Phase 3
136
Guangzhou
2025-05-15
Recruiting
Preliminary Human Trials of F230 Tablets
NCT06899815Pulmonary Hypertension
Beijing Continent Pharmaceutical Co, Ltd.
Phase 1
136
Hubei
2025-05-15
By invitation
A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection
NCT06717932Beta-Thalassemia
CorrectSequence Therapeutics Co., Ltd
Observational
8
Nanning
2025-05-15
Recruiting
Safety and Efficacy of Pucotenlimab in pLECC
NCT06969534Lymphoepithelioma-like Carcinoma, Lymphoepithelioma, Carcinoma
Sun Yat-sen University
Phase 2
33
Guangzhou
2025-05-15
Recruiting
Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer
NCT06949098Rectal Cancer Stage I
Hebei Medical University Fourth Hospital
Phase 2
60
Shijiazhuang
2025-05-15
Recruiting
A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors
NCT06926283Prostate Cancer, Other Solid Tumors, Ewing Sarcoma
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1
110
Changsha, Hangzhou, Beijing
2025-05-15
Recruiting
A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer
NCT06970119Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd
Phase 1/2
55
Wuxi, Tianjin
2025-05-14
Recruiting
Evaluation of the Clinical Efficacy of Antrrix Probiotics in Improving Recurrent Respiratory Infections in Infants and Young Children
NCT07297966Recurrent Respiratory Tract Infections
Min-Tze LIONG
Phase 2
120
Xingyi
2025-05-14
Active, closed
A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Abdominal Surgery
NCT06890533Pain
Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Phase 3
560
Cangzhou, Changde, Changsha, Chengdu, Chongqing, Chโ€™ang-chโ€™un, Dalian, Deyang
2025-05-14
Recruiting
Rapamycin-Eluting Vertebral Stents In The Real-World Treatment of Symptomatic Intracranial Atherosclerotic Stenosis
NCT07352852Intracranial Arterial Stenosis, Brain Diseases
The Affiliated Hospital of Qingdao University
Observational
300
Qingdao
2025-05-14
Active, closed
The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer
NCT06824259Prostate Cancer
Peking University First Hospital
Not applicable
400
Beijing
2025-05-14
Recruiting
Nasopharyngeal Airway Combined With Nasal High-flow Oxygen Therapy During Painless Gastroscopy in Obesity Patients
NCT06966934Hypoxia, Obesity, Gastrostomy
Nanjing First Hospital, Nanjing Medical University
Not applicable
364
Nanjing
2025-05-14
Recruiting
Comparison of Sequential to Initial Combination Therapy in PAH
NCT06968962Pulmonary Arterial Hypertension (PAH)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
376
Hangzhou
2025-05-14
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
NCT06925737Prostate Cancer, Prostatic Neoplasms
Merck Sharp & Dohme LLC
Phase 3
1,440
Beijing, Chongqing, Fuzhou, Guangzhou, Zhuhai, Nanning, Zhengzhou, Wuhan
2025-05-13
Recruiting
Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver Metastases
NCT07117435Colorectal Liver Metastases, First-line Treatment
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1
7
Lishui
2025-05-13
Rows per page Showing 8001–8100 of 19052
Previous 79 80 81 82 83 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=81

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.